Impact of Prepregnancy Maternal Fasting Glucose Levels on Pregnancy and Neonatal Morbidity in Women With Pregestational Diabetes Mellitus.

ABSTRACT:

Background

Managing blood glucose levels before conception and during pregnancy is crucial for ensuring optimal maternal and fetal outcomes. However, little is known about the impact of maintaining fasting plasma glucose (FPG) levels within a specific range on pregnancy and neonatal morbidities, especially in women with diabetes mellitus (DM). We aimed to evaluate the effects of maternal prepregnancy FPG levels on pregnancy and neonatal morbidity in women with pregestational DM.

Methods

This retrospective nationwide study included singleton pregnant women diagnosed with DM who underwent health screening. We compared the risk of adverse pregnancy outcomes (APOs) and neonatal morbidity based on prepregnancy FPG levels. Multivariate analyses were performed to estimate odds rati

SUBMITTER: Jung YM 

PROVIDER: S-EPMC12559654 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature